Janet Fricker. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents/economicsAntineoplastic Agents/therapeutic useCost-Benefit AnalysisDrug Costs/legislation & jurisprudenceDrug Industry/economicsDrug Industry/legislation & jurisprudenceEnglandGovernment RegulationHealth Policy/economicsHealth Policy/legislation & jurisprudenceHealth Services Accessibility/economicsHealth Services Accessibility/legislation & jurisprudenceHumansPolicy MakingState Medicine/economicsState Medicine/legislation & jurisprudence
Substances: See more » Antineoplastic Agents
Year: 2017 PMID: 28343973 DOI: 10.1016/S1470-2045(17)30235-8
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316